323. Aromatic L-amino acid decarboxylase deficiency Disease details / Clinical trials / Drug dev / DR info
Clinical trial : 0 / Drug : 0 - (DrugBank : 0) / Drug target gene : 0 - Drug target pathway : 0
Aromatic L-amino acid decarboxylase deficiency and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
ID | Diseases (Sorted by score) | Score |
---|---|---|
323 | Aromatic L-amino acid decarboxylase deficiency | - |
6 | Parkinson disease | 3.000 |
21 | Mitochondrial disease | 3.000 |
13 | Multiple sclerosis/Neuromyelitis optica | 3.000 |
2 | Amyotrophic lateral sclerosis | 3.000 |
17 | Multiple system atrophy | 3.000 |
34 | Neurofibromatosis | 3.000 |
46 | Malignant rheumatoid arthritis | 3.000 |
65 | Primary immunodeficiency | 3.000 |
96 | Crohn disease | 3.000 |
280 | Huge arteriovenous malformation with cervicofacial or limb lesion | 3.000 |
90 | Retinitis pigmentosa | 3.000 |
8 | Huntington disease | 3.000 |
5 | Progressive supranuclear palsy | 3.000 |
113 | Muscular dystrophy | 3.000 |
78 | Hypopituitarism | 3.000 |
107 | Juvenile idiopathic arthritis | 3.000 |
206 | Fragile X syndrome | 3.000 |
226 | Interstitial cystitis with Hunners ulcer | 3.000 |
11 | Myasthenia gravis | 3.000 |
22 | Moyamoya disease | 3.000 |
70 | Spinal stenosis | 3.000 |
215 | Tetralogy of Fallot | 3.000 |
118 | Myelomeningocele | 3.000 |
288 | Autoimmune acquired coagulation factor deficiency | 3.000 |
169 | Menkes disease | 3.000 |
170 | Occipital horn syndrome | 3.000 |
4 | Primary lateral sclerosis | 3.000 |
254 | Porphyria | 3.000 |
212 | Tricuspid atresia | 3.000 |